A detailed history of Gladius Capital Management LP transactions in Iradimed Corp stock. As of the latest transaction made, Gladius Capital Management LP holds 1,727 shares of IRMD stock, worth $93,378. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,727
Previous 1,727 -0.0%
Holding current value
$93,378
Previous $86,000 -0.0%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$43.23 - $50.29 $41,716 - $48,529
965 Added 126.64%
1,727 $86,000
Q2 2024

Jul 18, 2024

SELL
$40.36 - $44.7 $2,260 - $2,503
-56 Reduced 6.85%
762 $33,000
Q1 2024

May 14, 2024

BUY
$41.17 - $47.29 $4,158 - $4,776
101 Added 14.09%
818 $35,000
Q4 2023

Feb 07, 2024

SELL
$37.31 - $47.47 $3,432 - $4,367
-92 Reduced 11.37%
717 $34,000
Q3 2023

Oct 10, 2023

BUY
$43.28 - $50.3 $35,013 - $40,692
809 New
809 $36,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $679M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.